CD90 Antikörper (N-Term)
-
- Target Alle CD90 (THY1) Antikörper anzeigen
- CD90 (THY1)
-
Bindungsspezifität
- AA 36-65, N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CD90 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Aufreinigung
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- Immunogen
- This THY1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 36-65 amino acids from the N-terminal region of human THY1.
- Klon
- RB03970
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product THY1 Primärantikörper
-
-
- Applikationshinweise
- WB: 1:1000. WB: 1:1000. IHC-P: 1:50~100. IHC-P: 1:10~50. IHC-P: 1:50~100
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
- Haltbarkeit
- 6 months
-
-
The clinical pathological significance of Thy1 and CD49f expression in chondrosarcomas." in: Pathology, research and practice, Vol. 212, Issue 7, pp. 636-42, (2017) (PubMed).
: "Quantitative Analysis of Differential Proteome Expression in Bladder Cancer vs. Normal Bladder Cells Using SILAC Method." in: PLoS ONE, Vol. 10, Issue 7, pp. e0134727, (2015) (PubMed).
: "Analogy between sphere forming ability and stemness of human hepatoma cells." in: Oncology reports, Vol. 24, Issue 5, pp. 1147-51, (2011) (PubMed).
: "High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma." in: Gut, Vol. 59, Issue 7, pp. 953-62, (2010) (PubMed).
: "
-
The clinical pathological significance of Thy1 and CD49f expression in chondrosarcomas." in: Pathology, research and practice, Vol. 212, Issue 7, pp. 636-42, (2017) (PubMed).
-
- Target
- CD90 (THY1)
- Andere Bezeichnung
- THY1 (THY1 Produkte)
- Synonyme
- CD90 antikoerper, CD7 antikoerper, T25 antikoerper, Thy-1 antikoerper, Thy-1.2 antikoerper, Thy1.1 antikoerper, Thy1.2 antikoerper, Thy-1 cell surface antigen antikoerper, thymus cell antigen 1, theta antikoerper, THY1 antikoerper, Thy1 antikoerper
- Hintergrund
- THY1 (CD90) antigen is a GPI linked glycoprotein member of the Immunoglobulin superfamily. It is expressed on murine T cells, thymocytes, neural cells, cells of granulocytic lineage, early hematopoietic progenitors, fibroblasts, neurons and Kupffer's cells. Thy1 may play a role in cell to cell or cell to ligand interactions during synaptogenesis and other events in the brain.
- Molekulargewicht
- 17935
- Gen-ID
- 7070
- NCBI Accession
- NP_006279
- UniProt
- P04216
- Pathways
- Cell-Cell Junction Organization
-